We aspire to become a private equity and asset management leader in the Asia-Pacific region.

We aim to capture recurring, high yielding cash returns through investing in bespoke and defensively structured, secured debt packages and securitizations of performing and growing middle market borrowers.

The above three subsidiaries manage respectively four renminbi-denominated funds, including CDIB Private Equity (Fujian) Enterprise (focusing on the information and communication/Internet fields), CDIB Yida Private Equity (Kunshan) Enterprise (focusing on high-end manufacturing fields), CDIB Yida Healthcare Private Equity (Kunshan) Enterprise ...

Identify, screen and select top tier private equity fund managers, and maintain an active pipeline of new funds Conduct rigorous due diligence and analysis to evaluate each individual fund investment Analyze and identify the best performing managers within a specific private equity strategy with relevant private and public benchmarks, and make final recommendations Prepare all relevant ...

We seek to invest alongside top tier private equity fund managers, leveraging on CDIB Capital’s direct investment expertise and the broader KGI Financial platform, with its broad network of relationships with the world’s best private equity funds, leading to attractive and best-in-class investment opportunities.

We offer full support, from corporate governance to capital market, to help WellJoint (Shanghai) Technology make a stand in the industry, become a listed company, and achieve milestones along the way.

Co-Investment We seek to invest alongside top tier private equity fund managers, leveraging on CDIB Capital’s direct investment expertise and the broader KGI Financial platform, with its broad network of relationships with the world’s best private equity funds, leading to attractive and best-in-class investment opportunities. Portfolio ...

We seek to invest alongside top tier private equity fund managers, leveraging on CDIB Capital’s direct investment expertise and the broader KGI Financial platform, with its broad network of relationships with the world’s best private equity funds, leading to attractive and best-in-class investment opportunities.

Its unique business model, excellent execution, and international team are the key reasons why we think FunNow has huge potential. The company was one of the first investment teams we invested in after establishing the CDIB Capital Innovation Accelerator Fund in 2017.

We focus on high-potential startups in biotech and pharmaceuticals, med-tech, and digital health care industries, along with broader biomedical and healthcare service sectors.